People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RevOpsis Therapeutics, Inc. | — | Biotechnology | Series A | $9.1M | $2.6M | 2022 |
| Zay Products Inc. | — | Other | Pre-Seed | $573K | $8.6M | 2021 |
| RevOpsis Therapeutics Corp | — | Biotechnology | Pre-Seed | $521K | $9.9M | 2022 |
Jeff Olson at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jeff Olson on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ramanath Bhandari | 2 | 2 |
| Ram Palanki | 2 | 2 |
| Jeff P Olson | 1 | 1 |
| Ram P Palanki | 1 | 1 |
| Karen Deitesfeld | 1 | 1 |
| Rex Deitesfeld | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.